Friday, July 20, 2018
 
 
Company News: Page (1) of 1 - 07/12/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Pluton Biosciences, a St. Louis-based biotech start-up, discovers new ways to stop Zika virus.
 
(July 12, 2018)
Pluton Biosciences, a St. Louis-based biotech start-up, discovers new ways to stop Zika virus.

PLUTON BIOSCIENCES FILES FOR PATENT ON FIRST DISCOVERY

Each year, mosquitoes kill approximately 725,000 people by spreading blood-borne disease and viruses.

And one species, the Aedes aegypti mosquito, has been notably destructive. Aedes is a vector for dengue and yellow fever, Chikungunya, and the Zika virus, which emerged in 2015 causing birth defects in children of mothers who carry the virus.



For many companies, a cure would involve treating the disease only after a person has been infected.

But for Pluton Biosciences, a St. Louis-based biotech start-up, a cure means stopping the diseases before they start.

Using its industry disrupting Micromining™ process, in just three months time Pluton Biosciences was able to identify two novel bacterial solutions to kill the Aedes larvae, opening a new path to explore in mosquito vector control. Pluton filed to patent these new biopesticides in April 2018.

How is finding a solution in three months possible?

Pluton uses its proprietary Micromining™ platform to “mine" billions of microbes from a collection of diverse soil samples. By fusing classic microbiology assay design to automation, image capture techniques, and computational biology, Micromining™ quickly and inexpensively isolates microbes with novel modes of action 100 times faster than current leading research labs.

But Pluton Biosciences is more than just a research company.

By partnering with manufacturers to create natural bioproducts for the pesticide, agriculture, pharmaceutical, and bioremediation industries, Pluton Biosciences aspires to solve global problems and helps ensure a sustainable future for our planet.

Pluton Biosciences can be reached by calling (314) 575-8355, emailing [email protected], or visiting plutonbio.com.

Pluton Biosciences, building a sustainable tomorrow by Micromining Nature's Solutions™ today.

Read the full story at https://www.prweb.com/releases/2018/07/prweb15619349.htm.


Page: 1


Related Keywords:
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • Healthcare IT Market 2018 - 2023 with SWOT Analysis regarding upcoming Changes and Technology Adaptations in Global Healthcare Sector
  • Vision Care Product Market To Witness Enhanced Growth Owing To Rising Occurrence Of Eye Disorders Till 2021 | Million Insights
  • Global Prosthetic Heart Valve Market Reaching at a CAGR of +12.70% by Geography, Deployment Model, Component, and Key players are Boston Scientific Cardiology, CryoLife, Inc., Abbott
  • Trauma Fixation Global Market to Register Steady Expansion During 2018-2025
  • Global Surgical Apparel Market Will Reach USD 2,966.58 million by 2024: Zion Market Research

    Cancer
  • Mesothelioma is a Deadly Cancer and it’s Completely Preventable
  • HedgePath Pharmaceuticals Granted Exclusive Option to License UCONN's Patented Chemical Analogues of Itraconazole
  • Alligator Bioscience Submits Application to Start Clinical Phase I Study in Cancer Patients with ATOR-1015, a Unique CTLA-4 and OX40 Binding Antibody
  • Yisheng Biopharma Announces Opening of New Business Divisions in Cambodia, Expanding Presence within Southeast Asia
  • Omega-3 Market to Reach US$ 16.37 Bn by 2023, Globally - QYResearch.com
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines